Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January -
February
-
March
-
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
- 2020 -
2021
-
2022
-
2023
-
2024
-
2025
January 2020 - 37 products
L
IP
Rinvoq 30 mg
28
765.24
848.65
10 %
Delayed release tablets: Upadacitinibum 30 mg
AbbVie AG
B / SL
FB
G
L
IP
Rinvoq 45 mg
28
1744.75
1913.95
10 %
Delayed release tablets: Upadacitinibum 45 mg
AbbVie AG
B / SL
FB
G
L
IP
CI
Nurofen Junior forte
Erdbeer
100 ml
3.98
13.55
10 %
Reckitt Benckiser
(Switzerland) AG
B / SL / SG
FB
G
L
IP
CI
Posaconazol Accord 40
mg/ml
105 ml
513.14
574.50
10 %
Accord Healthcare AG
B / SL / SG
FB
G
L
IP
CI
Atomoxetin-Mepha 10 mg
7
8.00
17.85
10 %
Capsules: Atomoxetinum 10 mg
Mepha Pharma AG
● 
A / SL / SG
FB
G
L
IP
Atomoxetin-Mepha 18 mg
7
8.00
17.85
10 %
Capsules: Atomoxetinum 18 mg
Mepha Pharma AG
● 
A / SL / SG
FB
G
L
IP
Atomoxetin-Mepha 18 mg
28
32.01
50.70
10 %
Capsules: Atomoxetinum 18 mg
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
Atomoxetin-Mepha 25 mg
7
8.00
17.85
10 %
Capsules: Atomoxetinum 25 mg
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
Atomoxetin-Mepha 25 mg
28
32.01
50.70
10 %
Capsules: Atomoxetinum 25 mg
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
Atomoxetin-Mepha 40 mg
7
8.00
17.85
10 %
Capsules: Atomoxetinum 40 mg
Mepha Pharma AG
● 
A / SL / SG
FB
G
L
IP
Atomoxetin-Mepha 40 mg
28
32.01
50.70
10 %
Capsules: Atomoxetinum 40 mg
Mepha Pharma AG
● 
A / SL / SG
FB
G
L
IP
Atomoxetin-Mepha 60 mg
28
32.01
50.70
10 %
Capsules: Atomoxetinum 60 mg
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
Atomoxetin-Mepha 80 mg
28
41.59
61.00
10 %
Capsules: Atomoxetinum 80 mg
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
Atomoxetin-Mepha 100 mg
28
41.59
61.00
10 %
Capsules: Atomoxetinum 100 mg
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
CI
Fulphila 6 mg
1001.72
1105.85
10 %
Injection solution: Pegfilgrastimum 6mg / 0.6ml
Medius AG
A / SL
FB
G
L
IP
Beovu 120mg/1ml
652.91
726.50
10 %
Injection solution in prefilled syringe: Brolucizumabum 120 mg/ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Ziextenzo 6 mg / 0.6 ml
1001.72
1105.85
10 %
Injection solution in prefilled syringe: Pegfilgrastimum 6mg / 0.6ml
Sandoz
Pharmaceuticals AG
A / SL
FB
G
L
IP
Ultomiris 300 mg/30 ml
4035.61
4181.60
10 %
Concentrate for infusion: Ravulizumabum 300mg / 30ml
Alexion Pharma GmbH
A / SL
FB
G
L
IP
Ultomiris 300 mg/3 ml
4035.61
4181.60
10 %
Concentrate for infusion: Ravulizumabum 300mg / 3ml
Alexion Pharma GmbH
A / SL
FB
G
L
IP
Ultomiris 1100 mg/11 ml
14797.24
15223.00
10 %
Concentrate for infusion: Ravulizumabum 1100mg / 11ml
Alexion Pharma GmbH
A / SL
FB
G
L
IP
CI
Rinvoq 15 mg
28
765.24
848.65
10 %
Delayed release tablets: Upadacitinibum 15 mg
AbbVie AG
B / SL
FB
G
IP
CI
Pennsaid 2 g / 100 g
56 g
13.01
24.05
10 %
Gel: Diclofenacum Natricum 20 mg
Gebro Pharma AG
D / SL
FB
G
IP
CI
Pennsaid 2 g / 100 g
112 g
22.90
42.30
10 %
Gel: Diclofenacum Natricum 20 mg
Gebro Pharma AG
D / SL
FB
G
L
IP
CI
V/S
HyQvia 100 mg/ml
1 +
165.68
196.60
10 %
Infusionslösung zur subkutanen Anwendung: Immunoglobulinum Humanum Normale 100 mg/ml
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
V/S
HyQvia 100 mg/ml
1 +
331.35
376.80
10 %
Infusionslösung zur subkutanen Anwendung: Immunoglobulinum Humanum Normale 100 mg/ml
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
V/S
HyQvia 100 mg/ml
1 +
662.71
737.15
10 %
Infusionslösung zur subkutanen Anwendung: Immunoglobulinum Humanum Normale 100 mg/ml
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
V/S
HyQvia 100 mg/ml
1 +
1325.41
1457.90
10 %
Infusionslösung zur subkutanen Anwendung: Immunoglobulinum Humanum Normale 100 mg/ml
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
V/S
HyQvia 100 mg/ml
1 +
1988.12
2178.60
10 %
Infusionslösung zur subkutanen Anwendung: Immunoglobulinum Humanum Normale 100 mg/ml
Takeda Pharma AG
B / SL
FB
G
IP
CI
Nurofen Junior forte
Erdbeer
30 ml
PR
PR
k.A.
Reckitt Benckiser
(Switzerland) AG
B
FB
G
IP
CI
Nurofen Junior forte
Erdbeer
50 ml
PR
PR
k.A.
Reckitt Benckiser
(Switzerland) AG
B
FB
G
IP
CI
Nurofen Junior forte
Erdbeer
150 ml
PR
PR
k.A.
Reckitt Benckiser
(Switzerland) AG
B
FB
G
IP
Crysvita 10 mg/1 ml
PR
PR
k.A.
Injection solution: Burosumabum 10 mg/ml
Kyowa Kirin Sàrl
B
FB
G
IP
Crysvita 20 mg/1 ml
PR
PR
k.A.
Injection solution: Burosumabum 20 mg/ml
Kyowa Kirin Sàrl
B
FB
G
IP
Crysvita 30 mg/1 ml
PR
PR
k.A.
Injection solution: Burosumabum 30 mg/ml
Kyowa Kirin Sàrl
B
FB
G
IP
CI
Ziextenzo 6 mg / 0.6 ml
24
26378.16
27283.60
k.A.
Injection solution in prefilled syringe: Pegfilgrastimum 6mg / 0.6ml
Sandoz
Pharmaceuticals AG
A
FB
G
IP
CI
Rüedi Xylo PLUS
Nasenspray
10 ml
PR
PR
k.A.
Nasal spray: 2 Active Agents
Spirig HealthCare AG
D
FB
G
CI
H
Similasan Reise-
Beschwerden N
60
PR
PR
k.A.
Tablets: 4 Active Agents
Similasan AG
D
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home